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S U M M A R Y
Despite the presence of dengue in Sri Lanka since the early 1960s, dengue has become a major public
health issue, with a high morbidity and mortality. Aedes aegypti and Aedes albopictus are the vectors
responsible for the transmission of dengue viruses (DENV). The four DENV serotypes (1, 2, 3, and 4) have
been co-circulating in Sri Lanka for more than 30 years. The new genotype of DENV-1 has replaced an old
genotype, and new clades of DENV-3 genotype III have replaced older clades. The emergence of new
clades of DENV-3 in the recent past coincided with an abrupt increase in the number of dengue fever
(DF)/dengue hemorrhagic fever (DHF) cases, implicating this serotype in severe epidemics. Climatic
factors play a pivotal role in the epidemiological pattern of DF/DHF in terms of the number of cases,
severity of illness, shifts in affected age groups, and the expansion of spread from urban to rural areas.
There is a regular incidence of DF/DHF throughout the year, with the highest incidence during the rainy
months. To reduce the morbidity and mortality associated with DF/DHF, it is important to implement
effective vector control programs in the country. The economic impact of DF/DHF results from the
expenditure on DF/DHF critical care units in several hospitals and the cost of case management.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Dengue viruses (DENV) are mosquito-borne ﬂaviviruses that
have plagued humans for centuries. Urbanization and human
population growth in the tropical regions of the world have
produced favorable conditions for DENV transmission. Moreover,
changes due to urbanization and human population growth have
led to the current global dengue pandemic, characterized by a
dramatic increase in DENV infections and an expanding geographic
distribution of both DENV and the mosquito vectors,1 Aedes aegypti
and Aedes albopictus, which transmit DENV among humans.2
In Sri Lanka, 48 Aedes species belonging to 11 subgenera have
been reported to date. The subgenera are Aedimorphus, Can-
craedes, Christophersiomyia, Diceromyia, Finlaya, Mucidus, Neo-
melaniconion, Paraedes, Rhinoskusea, Stegomyia, and Verrallina.
The established DENV vectors A. aegypti and A. albopictus belong
to the subgenus Stegomyia.3,4 However, nothing is known about* Corresponding author. Tel.: +94 81 2396532; fax: +94 81 2389106.
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http://dx.doi.org/10.1016/j.ijid.2013.10.012the role of the remaining 46 Aedes species in DENV carriage and
transmission, an area that might shed some light on how DENV
survive the intra-epidemic periods.
Sri Lanka has been affected by dengue fever (DF)/dengue
hemorrhagic fever (DHF) epidemics for over two decades. DENV
infections have been endemic in Sri Lanka since the mid 1960s. DF
was serologically conﬁrmed in the island in 1962.5 The presence of
DF in all of the major towns situated below 1200 m elevation was
conﬁrmed in 1966 and in 1976–1978.6
In Sri Lanka, DF control efforts have been targeted at the disease
and vector, including laboratory surveillance for DENV infections
in patients and vectors, vector control, social mobilization, clinical
management of DF/DHF patients, and the emergency response
during outbreaks in terms of accelerated vector control and public
awareness through the media. A national-level multidisciplinary
task force on DF/DHF has been established to govern the DF/DHF
control activities. Furthermore, there are provincial and district-
level DF/DHF control activities in place. Training clinicians on
clinical management has been carried out continually in an
attempt to bring the DF/DHF mortality to zero, or to a minimum
level. It is hoped that with the implementation of collective control
programs in collaboration with other governmental and non-
governmental organizations, with maximum cooperation from the
community, the morbidity and mortality of DF/DHF will be
reduced in the near future.5ociety for Infectious Diseases. Open access under CC BY-NC-ND license.
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DENV is a ﬂavivirus transmitted by Aedes spp mosquitoes. There
are four antigenically distinct DENV serotypes, DENV 1–4.
Infection with a single DENV serotype leads to long-term
protective immunity against that particular serotype, but not
against the other serotypes.7 Thus prior infection with a single
serotype of DENV only provides a homotypic protection.
The origin of DENV has been reported to be African, with the
distribution of DENV around the world occurring as a result of the
slave trade.8,9 Conversely, it is believed that DENV may have
originated in a forest cycle involving lower primates and canopy-
dwelling mosquitoes in the Malay Peninsula.9,10 It is possible that
different DENV serotypes evolved in taxonomically related mosquito
species in different geographical regions. All four DENV serotypes
havebeendocumentedinaforestcycle inAsia,whileonlyone(DENV-
2) has been documented in Africa.10 It is currently thought that DENV
probably had an Asian origin, which is supported by serosurveys
conducted in rural communities of Malaysia in the early 1950s.9
Biologically, DENV are highly adapted to their mosquito host
and are maintained in the mosquito species responsible for forest
cycles, with periodic ampliﬁcation in lower primates.10 In the past,
due to the clearing of forests and the development of human
settlements, DENV has moved out of the jungle and rural
environment from where they were and still are transmitted to
humans by mosquitoes. Due to the migration of people and
commerce, DENV have ultimately moved into the villages, towns,
and cities of tropical Asia, where these viruses are most likely to be
transmitted sporadically by A. albopictus and other closely related
peri-domestic Stegomyia species.1
The four serotypes of DENV have been co-circulating in Sri
Lanka for more than three decades and their distribution has not
changed drastically in the last 30 years. Although the Sri Lankan
population had been exposed to DENV for a long time, the severe
forms of DENV infection (DHF and dengue shock syndrome (DSS))
were rare before 1989. Studies have shown the existence of more
than one DENV serotype in many parts of the country. There was an
island-wide epidemic of DF associated with DENV serotypes 1 and
2 from 1965 to 1968. This epidemic caused 51 DHF cases and 15
deaths.5 DENV-1 and DENV-2 were isolated from the outbreaks in
1965 and 1966.11
A study conducted using mosquito pools in the Western and
North-Western provinces of Sri Lanka, including the districts of
Colombo, Gampaha, and Kurunegala, has indicated the circulation
of multiple DENV serotypes within close proximity to each other.12
Mosquito pools from Kurunegala district were positive for both
DENV-2 and DENV-4, while mosquito pools from Gampaha and
Colombo districts had DENV-2 and DENV-4. Higher numbers of
positive pools of DENV-1 and DENV-4 have been reported in
Kurunegala.12
The results of another study performed between 2003 and
2006, indicate the circulation of the DENV-1 serotype in the
Colombo district of Sri Lanka.13 However, this study showed a
change in the genetic characteristics of the DENV-1 serotype
during the study period. The two isolates of DENV-1 serotype from
Sri Lanka obtained in 1983 and 1984 belonged to the South Paciﬁc
genotype, and it is believed that some time during the period
1984–1997, the Africa/America genotype of the DENV-1 serotype
became established in Sri Lanka; this new genotype of the DENV-1
serotype continued to circulate through 2004. Moreover, the South
Paciﬁc genotype of the DENV-1 serotype has not been detected
during the past 8 years in Sri Lanka.
In 2009, the largest epidemic of DF/DHF occurred in Sri Lanka
(35 008 reported cases, 170 cases/100 000 population, and 346
deaths) and that outbreak was found to have been caused by a new
strain of the DENV-1 serotype.14 Results from DENV nucleic aciddetection by reverse transcription (RT)-PCR in patients with DHF
from August 2010 to December 2010 showed the predominance of
the DENV-1 serotype, which accounted for more than 95% of DF/
DHF cases in the Western Province of Sri Lanka;15 this is similar to
the observations made by the Epidemiology Unit of Sri Lanka
during that period. Therefore, it appears that the serotype shift
may have contributed in some way to the larger DF/DHF outbreaks
in the last 2–3 years in the country.
All DENV-2 isolates from Sri Lanka are closely related and
belong to the Indian subcontinent/Malaysia genotype. Moreover,
there is no evidence of any recent introduction of a DENV-2 strain
from outside the island, because the DENV-2 strains from Sri Lanka
are more closely related to one another than to any other DENV-2
strain.13
DENV-3 strains from Sri Lanka isolated in the 1980s and 1990s
belong to the Indian subcontinent genotype (III).16,17 Genotype III
of the DENV-3 strains from Sri Lanka are divided into two distinct
clades linked to mild (IIIA) and severe (IIIB) disease epidemics in
the island.16 Moreover, the DENV-3 strains from Sri Lanka isolated
in 2003 and 2004 form a new distinct clade that is closely related
but different from the DENV-3 clade IIIB viruses that were isolated
in the 1990s. This new 2003/2004 clade includes an isolate from
1993, which strongly suggests that the clade is derived from strains
that have been circulating on the island for some time.13
Unlike group A viruses, the Sri Lankan group B viruses may be
associated with severe disease, as the group B viruses are
inherently more virulent. Alternatively, the ability of pre-existing
antibodies against DENV to neutralize group A viruses but enhance
group B viruses may account for the severe disease in group B
DENV-3 infections but mild disease in group A DENV-3 re-
infections. DENV-2 and DENV-3 are the common serotypes
reported in many parts of Sri Lanka. Individuals with previous
primary DENV-2 infections have been shown to neutralize the
DENV-3 group A viruses better than the DENV-3 group B viruses,
and this might be contributing to the severe disease in group B
DENV-3 infections.18
In Sri Lanka, regular epidemics of DF/DHF have been observed
only since 1989. DENV-3 is responsible for many of the infections
that progress to DHF.19,20 DENV-3 isolates obtained before and after
the emergence of DHF are very closely related and belong to subtype
III, indicating that the emergence of DHF in the island was not due to
the introduction of a new subtype of DENV-3 from outside. During
DENV surveillance studies in 1997, only DENV-3 was isolated from
hospitalized DF cases, whereas DENV- 1, DENV-2, and DENV-3 were
isolated from patients visiting outpatient clinics.21 These observa-
tions suggest that DENV-3 is responsible for severe DF in Sri Lanka.
However, further studies are required to establish the relative
contribution of DENV-3 to severe DF/DHF in Sri Lanka.
The DENV-4 strain isolated in Sri Lanka in 1978 and in 2003/2004
wastheSoutheastAsiangenotype,whichindicatesthatthisgenotype
is established and has been circulating in the island for decades. Two
DENV-4isolatesfrom1992belongtotheIndonesiangenotype,which
might represent a transient introduction to the island.13
In 2003, DENV-1 and DENV-4 showed a genotype switch, which
is not observed in the phylogeny of DENV-2 and DENV-3. Instead,
new clades of DENV-3 genotype III viruses have replaced older
clades, and DENV-2 has also shown a similar trend. The emergence
of new clades of DENV-3 in 1989 and 2000 coincided with abrupt
increases in the numbers of reported DF cases, implicating this
serotype in severe epidemics (Table 1).16
3. Changes in the epidemiology of DF/DHF and DENV infection
in the vectors
Globally DF was initially an ‘urban’ disease, in that the
epidemics mainly occurred in densely populated urban settings.
Table 1
Changes in the outbreak DENV types over time in Sri Lanka
Year DENV serotype responsible for major
DF/DHF outbreaks in Sri Lanka
Ref.
1965 DENV-1, DENV-2 5, 11
1968 DENV-1, DENV-2 5, 11
1978 DENV-4 13
1980 DENV (IIIA) 16, 17
1990 DENV (IIIA) 13, 16, 17
1992 DENV-4 13
1993 DENV (IIIB) 21
1997 DENV (IIIB) 21
2003 DENV (IIIB), DENV-4 13




DENV, dengue virus; DF, dengue fever; DHF, dengue hemorrhagic fever.
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changed with the disease now spreading to rural areas as well.22
Epidemiologically, during the 19th century DF was considered
as a sporadic disease, causing epidemics at long intervals.
However, dramatic changes in the epidemic pattern have occurred
and DF/DHF currently is ranked as the most important mosquito-
borne viral disease in the world.23 DF is now one of the leading
causes of hospitalization and death among children in the tropical
regions of the world.24 The rapid increase in DENV activity in India
and Sri Lanka (Figure 1) from 1999 to 2003 suggests its potential to
cause even more severe epidemics in the future.23
Although vector densities are generally much higher in urban
areas when compared to rural settings, vector densities in the
latter are now seen to be increasing.25,26 Therefore, the potential
‘threat’ of major DF/DHF outbreaks in rural areas is imminent in the
tropical dengue endemic regions of the world. In Sri Lanka,
although the highest incidence of DF/DHF is seen in the Western
Province (44.9% in 2007), there has been a dramatic increase in the
incidence in all other provinces.25 In the recent past, the incidence
of DF/DHF has been more marked in the North Central Province
(11.8% in 2007 vs. 4.8% in 2004), Wayamba Province (15.9% in 2007
vs. 10.2% in 2004), and Sabaragamuwa Province (12.2% in 2007 vs.
6% in 2004 (Epidemiology Unit, Ministry of Health, Sri Lanka).
Therefore, there is a potential threat of severe DF/DHF epidemics
occurring throughout the country in the future.25
The mosquito A. aegypti has been thought to be the main vector
responsible for virtually all DF/DHF epidemics. A. albopictus has
been considered as a vector in which the DENV is maintained but
does not contribute to the transmission rate in epidemics. Aedes
mosquitoes are primarily container breeders and they thrive in
both clean and organically rich water in both natural and artiﬁcial
containers.27
An entomological study showed the presence and abundance of
A. albopictus in many of the locations in all of the districts surveyed.
Furthermore, in that study, 100% of the DENV-positive pools were
made of A. albopictus, highlighting the importance of A. albopictus
in the transmission of DENV. The ability of A. albopictus to be
infected with low virus loads and the degree to which it permits
replication within the mosquito itself could have an impact on the
maintenance and the transmission of DENV in the long run.27
Co-circulation of two or more DENV serotypes in a single pool or
in different pools of mosquitoes within the same district is
suggestive of hyper-endemic transmission of DENV in the districts
of Colombo, Gampaha, and Kurunegala.12 Thus there is evidence of
the capability of A. albopictus as a vector in transmitting DENV in
the absence or low abundance of A. aegypti. A. albopictus is under-
rated in the transmission of DENV, especially during the peaktransmission periods of DF/DHF in Sri Lanka.12 DF/DHF cases have
been encountered in areas where there is no A. aegypti breeding,
but A. albopictus breeding is prevalent.28 In Kandy, a city in the
Central Province of Sri Lanka, four species of Aedes larvae were
collected from water storage tanks, with the majority being A.
albopictus (41.05%) and A. aegypti (13.43%); the remaining tanks
contained larvae of Aedes macdougalli (39.55%) and Aedes vittatus
(5.97%).29 The greater susceptibility of A. albopictus to DENV
infection is said to have led to greater DENV adaptation, thus Sri
Lanka as a whole may be at serious risk of multiple DF/DHF
outbreaks in the future with the evolution of DENV strains.12
A. aegypti and A. albopictus are widely adapted to urban and
suburban environments in Sri Lanka.30 Recent studies have shown
that A. aegypti and A. albopictus lay eggs in brackish water, and their
larvae and pupae survive to emerge as adults in brackish water
collections. Brackish water habitats have been identiﬁed with
Aedes larvae in the peri-urban areas of Sri Lanka. The brackish
water larval sites identiﬁed are located in popular beaches and in
coastal areas 1 km from densely populated residential areas; this
ﬁnding is consistent with the potential role of Aedes adapted to
brackish water in DENV transmission.31
The eastern coastal district of Batticaloa, which was devastated
by the 2004 Asian tsunami, lies in the dry zone of Sri Lanka and is
one of the districts badly affected by DF/DHF in recent years. A
seasonal shift in the density of the two Aedes species has been
observed in Batticaloa. A. aegypti tends to predominate during the
pre-monsoon season and A. albopictus during the monsoon season.
Since the monsoon rains fall in Batticaloa district from October to
December, the density of Aedes increases during this period and a
positive association between rainfall and Aedes density has been
observed.32 The high density of Aedes mosquitoes recorded in June
2008 has been attributed to the unexpected rain experienced in
that month.32
The continuous application of vector control methods solely in
freshwater pre-imaginal development habitats in the urban
environment may select for genetic changes in the DENV favoring
the development of A. aegypti and A. albopictus in artiﬁcial
collections of brackish water in coastal urban areas, which in
turn may lead to vector adaptation to natural brackish water
habitats in the future. Such changes could have serious con-
sequences for the health of millions of people in many parts of the
world, through a higher incidence of DF/DHF, chikungunya, and
urban yellow fever, as these are transmitted through Aedes
mosquitoes.33,34
The shift in various aspects of epidemiology of DF/DHF, as
observed in Sri Lanka, has been seen in other dengue endemic
countries in the world as well. Cyclical epidemics of DF/DHF have
been reported from several Asian countries, such as India, the
Philippines, and Thailand, with increasing numbers of cases from
the 1950s through the 1970s. Increases in disease transmission and
the frequency of epidemics have also been the result of circulation
of multiple serotypes in Asia.35 Of the 2.5 billion people around the
world living in dengue endemic countries with a risk of contracting
DF/DHF, nearly half live in 10 countries of the Southeast Asia
region. Nearly 75% of the current global disease burden due to DF/
DHF is reported in the Southeast Asia region together with Western
Paciﬁc region. Until 2003, only eight countries in the region had
reported DF/DHF cases. By 2009, all member states except the
Democratic Peoples’ Republic of Korea had reported DF/DHF
outbreaks. Korea is the only country in the Southeast Asia region
that has no reports of indigenous transmission of DENV. Timor-
Leste reported an outbreak in 2004 for the ﬁrst time. Bhutan also
reported its ﬁrst DF/DHF outbreak in 2004.35 Nepal reported its
ﬁrst indigenous case of DF in November 2004.35,36
In Indonesia, the number of reported DF/DHF cases started to
rise from 2004, reaching a plateau between 2007 and 2009, and is
Figure 1. Temporal and spatial distribution of DF/DHF in Sri Lanka: cases reported to the Epidemiology Unit, Sri Lanka (accessed August 17, 2013).
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Bangladesh, Myanmar, and the Maldives, DF/DHF follows an
endemic pattern. Moreover, there has been an increase in the
proportion of severe DF cases, particularly in Thailand, Indonesia,
and Myanmar.35,36 In India and Thailand, the prominent strain of
DENV has been DENV-1, which is linked to high morbidity and low
mortality.
In the early 1960s, DF/DHF cases were conﬁrmed in Sri Lanka by
antibody detection, either by IgM detection in a single serum
sample or by demonstrating an increase in the antibody levels in
paired sera. Cases occurred in epidemic proportions for the ﬁrst
time in Sri Lanka during 1965–1966 with sporadic cases of DHF.
Initially, the disease was mainly spread in the western coastal belt,
but it was later found in other suburbs as well. In 1965, there was a
DF outbreak throughout the country with 51 cases and 15 deaths.
After that, epidemics occurred in many parts of the country fairly
regularly, in 1966, 1967, 1968, 1972, 1973, and 1976, and the
number of cases reached a peak in 1988/1989.5,6
In 2002, DF/DHF was ranked as the third most common
notiﬁable disease in Sri Lanka (ﬁrst and second were malaria and
tuberculosis).37,38 In recent years, deaths due to DF/DHF have been
greater than those due to malaria, and DF/DHF is becoming the
number one killer mosquito-borne infection in Sri Lanka.37
Currently malaria is in the elimination phase in the country.
There are speciﬁc anti-malarial drugs for the malaria parasite and
the malaria parasites are more stable genetically than RNA bound
DENV; DENV are more prone to genetic changes, producing many
strains within a type. Anopheles mosquitoes are night biters, so
barrier protection becomes effective. Collectively, these factors
might have contributed to the effectiveness of malaria control
programs in the country. On the other hand, DF and DHF have
become established due to several factors: (1) there is no speciﬁc
antiviral drug for DENV and there is no effective vaccine as yet,
despite many ongoing studies and trials; (2) DENV are genetically
unstable RNA bound viruses and are more prone to genetic
changes; (3) populations are becoming exposed to new DENV
strains; (4) DENV vectors are day biters so barrier protection for
preventing exposure becomes ineffective. These factors together
might have contributed to the establishment of DENV in the
country, causing regular outbreaks of severe DF/DHF.
At present, DF and DHF are prevalent in many urban and semi-
urban areas of Sri Lanka with seasonal and periodic epidemics
occurring regularly in the island.27 In recent decades a higher
incidence of DF/DHF has occurred in the districts of Colombo,
Gampaha, Kalutara, Kurunegala, Kegalle, Ratnapura, and Kandy.39
From 2000 to 2008, the reported number of suspected and
serologically positive DF/DHF cases varied from 4749 to 15 643,involving 25–88 deaths, with a major epidemic in 2004.29 Since the
30-year ethnic conﬂict in the country came to an end in 2009, DF/
DHF has become endemic in northern and eastern Sri Lanka, with a
high incidence in the capital cities of the northern and eastern
provinces of the island, Jaffna and Batticaloa, respectively.40 This
spread of DF/DHF to the north and the east might be due to the
open movement of people in both directions from the south to the
north and east, and vice versa; this open movement of people for
trade and other purposes was absent or very limited during the
conﬂict era, prior to 2009.
Another important aspect of the epidemiology of DF/DHF in Sri
Lanka is the shift in the affected age group from children to adults;
also, in many age groups, males have predominantly been affected.
According to a regional study done by the World Health
Organization (WHO) in Sri Lanka based on reported cases from
1996 to 2005, there were consistently and signiﬁcantly larger
proportions of males with DF/DHF in those aged 15 years. This
male preponderance was reported in every province of the country.
Among those aged 1–4 and 5–14 years, there were signiﬁcantly
fewer male cases than expected, although there was some annual
variation.41 The highest incidence occurred in the 5–9 years age-
group.5 Before 2000, one large peak of DF/DHF cases was observed
in children and a few cases were observed in adults. After 2000,
two reported DF/DHF peaks were observed in children and young
adults. Moreover, the mean age of reported DF/DHF cases was
shown to have increased from 15 years in 1996 to 25 years in
2006.13
Provincial DF/DHF epidemiology in Sri Lanka underwent a
marked change between 1996 and 2005. The proportion of
reported DF/DHF cases from the Western Province, in which the
country’s largest city, Colombo, is situated, decreased from 84% in
1999 to 37% in 2003. The age distribution of reported cases shifted
from children aged less than 15 years making up more than 60% of
cases in 1996–1999 to less than 40% of cases in 2001–2005.41
4. Role of climatic factors in the spread of DENV
Climate (temperature, rainfall, and humidity) change due to
global warming can expand the geographical range of vector
mosquitoes, extend the disease transmission season, shorten the
gonotrophic cycle, and reduce the time taken for ingested viruses
to develop to infective stages in mosquitoes, thereby increasing the
propagation rates of arboviral diseases transmitted by A. aegypti
and A. albopictus.33,42–44
There is a strong positive correlation between DF/DHF out-
breaks and the rainfall pattern, which increases the number of
breeding habitats of Aedes vectors. In semi-arid areas in India, A.
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rainfall and water storage habits.45 In Southeast Asian countries
where the annual rainfall is greater than 200 cm, A. aegypti
populations are more stable and are established in urban, semi-
urban, and rural areas. However, in countries like Indonesia,
Myanmar, and Thailand, the mosquito densities are higher in semi-
urban areas than in urban areas due to the traditional water
storage practices.46
In contrast to the strong positive correlation between DF/DHF
outbreaks and the rainfall pattern in many tropical countries, in
some areas of the world DF/DHF outbreaks occur before the arrival
of the rainy season or in relatively dry areas. Conversely, even in
locations with a rainy season, such as Singapore, a positive
correlation between rainfall and vector population density could
not be found.47 In certain regions of the tropics where there are two
annual rainy seasons, a positive correlation has been observed in
only one season.48 The impact of rainfall on adult vector density is
not the same for all vector species. A. aegypti prefers indoor
habitats, and hence it is less affected by rainfall than A. albopictus
and other vectors that have outdoor larval habitats.1
Two DF/DHF peaks occur annually in association with the
monsoon rains, when the densities of two mosquito vectors (A.
aegypti and A. albopictus) are high in Sri Lanka. Generally, the ﬁrst
peak occurs in June/July, coinciding with the south-western
monsoon that commences in late April. The second peak,
comparatively a smaller one, usually occurs at the end of the year
and is associated with the north-eastern monsoon rains that
prevail from October to December.5
Temperature is another important factor controlling the
seasonality of DF/DHF outbreaks in sub-tropical or temperate
regions. It inﬂuences vector distribution, the blood feeding activity
of the vector, the extrinsic incubation period, and adult longevity.
A. aegypti has been shown to transmit DENV when the temperature
is above 20 8C but not less than 16 8C. A positive correlation has
been shown between the temperature and the female vector
abundance. In addition, high temperatures may increase the
frequency of blood feeding due to a rapid reduction in energy
reserves.49 It is expected that global warming may further facilitate
the expanded distribution of DENV mosquito vectors in temperate
regions such as northern parts of North America and Europe.50 This
concern has become a far more serious matter with the expanding
distribution of A. albopictus.51
Altitude also plays a vital role in limiting the distribution of A.
aegypti. In India, A. aegypti breeding sites range from sea level to
1000 m above sea level. Lower elevations (less than 500 m) have
moderate to heavy mosquito populations, while mountainous
areas (over 500 m) have low populations.52
5. Prevention of DF/DHF
In the absence of a vaccine or speciﬁc antiviral treatment for DF
and DHF, preventive measures aim to reduce the population
density of the vectors, A. aegypti and A. albopictus. The control of
DF/DHF in tropical countries is mainly achieved through surveil-
lance of A. aegypti and A. albopictus larvae to eliminate the larval
development habitats, with the use of insecticides and public
education.53–54
A study conducted in the Kandy District of Sri Lanka showed
that the mechanical and biological measures alone are not
sufﬁcient to prevent Aedes breeding. This ﬁnding suggests the
need for an efﬁcient supplementary chemical method for Aedes
larval control in domestic water storage containers. Furthermore,
the prevention of A. aegypti and A. albopictus breeding in water
storage containers would greatly help to control DF/DHF.
Therefore, DF/DHF control programs should pay more attentionto the control of Aedes breeding in domestic water storage
containers.27
Effective waste collection and the proper disposal of garbage by
the local government bodies, commitment of individuals and
communities in reducing the source, and law enforcement against
the occupants of premises with Aedes mosquito breeding spots are
necessary for the control of DF/DHF in the country.
Countries like Thailand, Malaysia, and Cambodia55 have used
Temephos to prevent Aedes breeding in domestic water storage
jars and other water storage containers. The application of
Temephos sand granules to domestic water storage containers
in a ﬁeld trial in Bangkok, at a dosage of l ppm, resulted in a more
than 95% reduction in adult Aedes mosquito density.56 In Kandy,
the use of net covers for water storage cement tanks showed the
potential to control Aedes larvae including A. aegypti and A.
albopictus.27 Moreover, plastic net covers provide good Aedes
mosquito control in water storage cement tanks, and thus these
measures need to be included in the health messages in order to
encourage people to use such protective methods for the
prevention of DENV breeding, thereby eliminating the risk of
DF/DHF and chikungunya fever from the country.27
In Sri Lanka, District based DENV vector control programs
consist mainly of source reduction and thermal fogging. Fogging is
employed as a DENV vector control measure by the health
authorities during disease transmission periods.32 Malathion in
liquid form was used until 2008 and was replaced by Pesguard1 (a
synthetic pyrethroid) in 2009.32 Institutions such as hospitals,
transport bus depots, factories, and schools are also cited as
potential breeding areas for the DENV vectors. Discarded contain-
ers and water storage receptacles have been identiﬁed as
important breeding sites for Aedes mosquitoes in the country.
The control of DENV vectors is achieved largely through source
reduction, health education, and vector adulticiding with thermal
fogging in the country.
Another study done in Sri Lanka showed the possibility of using
a different mosquito, Toxorhynchites splendens, as an additional
measure for the control of A. albopictus breeding in man-made
water collecting containers.57 T. splendens has been used success-
fully in other countries like India to control Aedes. In an Indian
coastal village, there was a signiﬁcant reduction in the number of A.
aegypti breeding in domestic water containers 6 months after the
introduction of T. splendens.58 Second instar T. splendens larvae
have also been used successfully to suppress A. aegypti and A.
albopictus breeding in domestic water containers in Malaysia.59
Considering the nature of breeding of DENV vectors in various
districts, public awareness and continuous creative health educa-
tion are essential to control the transmission of DENV. It is
important that health authorities continue vector surveillance
throughout the dry and wet seasons to avoid any future outbreaks
in the country.32
6. Conclusions
Currently, DF/DHF cases are reported from all parts of Sri Lanka.
Two peaks in absolute number and incidence of DF/DHF occur
annually along with the monsoon rains, and the density of two
mosquito vector species (A. aegypti and A. albopictus) is higher in
these seasons. Generally, the ﬁrst peak occurs in June/July,
coinciding with the south-western monsoon, which commences
in late April. The second smaller peak usually occurs at the end of
the year and is associated with the north-eastern monsoon rains
that prevail from October to December.
Both A. aegypti and A. albopictus are prevalent in the country and
natural infections have been reported in both vectors. The studies
conducted in Sri Lanka indicate that A. albopictus is more efﬁcient
in DENV transmission at present. Both Aedes species were found to
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malathion.
For the last 30 years all four DENV serotypes have been
circulating in Sri Lanka. DENV-1 only accounted for 7% of
infections. DENV-2 and DENV-3 were the predominant circulating
serotypes until 2009 and were responsible for 86% of DENV
infections. In the last decade, new genotypes of DENV-1 and new
clades of DENV-3 (genotype III) have replaced the older ones, and
these are the reasons for the recent DF/DHF epidemics.
A pattern in the DF/DHF outbreaks can be seen in the country,
occurring with the monsoon showers. The recent extended rainy
season with heavy rains and ﬂoods could be one of the reasons for
DF/DHF becoming rampant and more unmanageable in the last 5
years in the island. The rains have been so torrential and heavy that
the taking of timely precautions against the outbreak and spread of
diseases has become extremely difﬁcult. On the other hand, Sri
Lanka cannot afford to make mistakes in predicting DF/DHF
outbreaks as the consequences could be catastrophic. A collective
approach to the control of DF/DHF, including environmental
control in source reduction of the vectors, cumulative climatic
forecast data, and mapping for outbreak prediction and case
management at its best (as practiced now) may be useful in
reducing the DF/DHF burden of this island nation. Although,
establishing a collective control program and sustaining that
program will be a difﬁcult task, Sri Lanka should remain positive
about sustaining the control program if lessons learned from its
successful control of malaria are followed.
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